Abstract
Factor XIIIa plays an important role in stabilization of formed fibrin clot during blood coagulation. Recent studies proved that factor XIIIa affects formation of coated platelets, which are highly procoagulant and characterized by a high level of alpha-granular proteins on their surface and expose surface phosphatidylserine after platelet activation. The ability of newly found cysteine proteinase inhibitors (CPIs) from plants to affect thiol group of the factor XIIIa active centre was recently discovered. Here, the effect of CPIs on the formation of coated platelets and activity of plasma components during blood coagulation process was investigated. It was found that CPIs dose-dependently decreased the fraction of coated platelets in the total platelet population during platelet activation and decreased endogenous thrombin potential (ETP) by 40% for thrombin generation in platelet-rich as well as in platelet-poor plasma. Such decrease of ETP could not be explained by the CPIs influence on factor XIIIa. Investigation of the effects of these inhibitors on factor Xa and thrombin activity has shown that CPIs dose-dependently inhibited their activity and might cause an ETP decrease. Thus, the obtained data indicated that CPIs affected both platelet and plasma components of blood coagulation system.
Similar content being viewed by others
Refernces
Zwaal, R.F.A. and Schroit, A.J., Pathophysiologic Implications of Membrane Phospholipids Asymmetry in Blood Cells, Blood, 1997, vol. 89, no. 4, pp. 1121–1132.
Alberio, L., Safa, O., Clemetson, K.J., Esmon, C.T., and Dale, G.L., Surface Expression and Functional Characterization of α-Granule Factor V in Human Platelets: Effect of Ionophore A23187, Thrombin, Collagen, and Convulxin, Blood, 2000, vol. 95, pp. 1694–1702.
Dale, G.L., Friese, P., Batar, P., Hamilton, S.F., Reed, G.L., Jackson, K.W., Clemetson, K.J., and Alberio, L., Stimulated Platelets Use Serotonin to Enhance Their Retention of Procoagulant Proteins on the Cell Surface, Nature, 2002, vol. 415, pp. 175–179.
Sane, D.C., Kontos, J.L., and Greenberg, C.S., Roles of Transglutaminases in Cardiac and Vascular Diseases, Bioscience, 2007, vol. 12, pp. 2530–2545.
Serrano, K., and Devine, D.V., Intracellular Factor XIII Cross Links Platelet Cytoskeletal Elements upon Platelet Activation, Thromb. Haemost., 2002, vol. 88, pp. 315–320.
Greenberg, C.S., Birckbichler, P.J., and Rice, R.H., Transglutaminases: Multifunctional Cross-Linking Enzymes that Stabilize Tissues, FASEB J., 1991, vol. 5, pp. 3071–3077.
Kostanova, E.A., Rosenfel’d, M.A., Revina, T.A., and Valueva, T.A., Protein Inhibitors of Fibrin-Stabilizing Factor XIII, Izvestiya Academii Nauk (Rus.), 2007, vol. 3, pp. 347–353.
Sugimura, Y., Hosono, M., Wada, F., Yoshimura, T., Maki, M., and Hitomi, K., Screening for the Preferred Substrate Sequence of Transglutaminase Using a Phage-Displayed Peptide Library. Identification of Peptide Substrates for TGase2 and Factor XIIIa, J. Biol. Chem. 2006, vol. 281, no. 26, pp. 17 699–17 706.
Lewis, S.D., Janus, T.J., Lorand, L., and Shafer, J.A., Regulation of Formation of Factor XIIIa by its Fibrin Substrates, Biochemistry, 1985, vol. 24, pp. 6772–6777.
Arnon, R. and Shapira, E., Antibodies to Papain. A Selective Fractionation According to Inhibitory Capacity, Biochemistry, 1967, vol. 6, no. 12, pp. 3942–3950.
Davieva, D.T. and Law, A.J., An Improved Method for the Quantitative Fraction of Casein Mixtures Using Ion-Exchange Chromatography, J. Dairy Res., 1977, vol. 44, pp. 213–221.
Laemmli, U.K., Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4, Nature, 1970, vol. 227, no. 5259, pp. 680–685.
Cooke, R.D., and Holbrook, J.J., Calcium and the Assay of Human Plasma Clotting Factor XIII, Biochem. J., 1974, vol. 141, pp. 71–78.
Israels, E.D., Paraskevas, F., and Israels, L.G., Immunological Studies of Coagulation Factor XIII, J. Clin. Invest., 1973, vol. 52, no. 10, pp. 2398–2403.
Lorand, L., Parameswaran, K.N., Velasco, P.T., Hsu, L.K., and Siefring, G.E. Jr., New Colored and Fluorescent Amine Substrates for Activated Fibrin Stabilizing Factor (Factor XIIIa) and for Transglutaminase, Anal. Biochem., 1983, vol. 131, no. 2, pp. 419–425.
Gorman, J.J. and Folk, J.E., Structural Features of Glutamine Substrates for Human Plasma Factor XIIIa (Activated Blood Coagulation Factor XIII), J. Biol. Chem., 1980, vol. 255, no. 2, pp. 419–427.
Hemker, H.C., Giesen, P.L.A., Ramjee, M., Wagenvoord, R., and Beguin, S., The Thrombogram: Monitoring Thrombin Generation in Platelet Rich Plasma, Thromb. Haemost., 2000, vol. 83, no. 4, pp. 589–591.
Hemker, H.C., Giesen, P.L.A., AlDieri, R., Regnault, V., de Smed, E., Wagenvoord, R., Lecompte, T., and Beguin, S., The Calibrated Automated Thrombogram (CAT): A Universal Routine Test for Hyper- and Hypocoagulability, Pathophysiol. Haemost. Thromb., 2002, vol. 32, nos. 5–6, pp. 249–253.
Jobe, S.M., Leo, L., Eastvold, J.S., Dickeneite, G., Ratliff, T.L., Lentz, S.R., and Paola, J.D., Role of FcRg and Factor XIIIA in Coated Platelet Formation, Blood, 2005, vol. 106, pp. 4146–4151.
Kohler, H.-P., Role of Blood Coagulation Factor XIII in Vascular Disease, Swiss Med. Wkly, 2001, vol. 131, pp. 31–34.
Ametov, A.S. and Kondrat’eva, L.V., Metaformin, Basic of Therapy Patient with Metabolic Syndrome, Endokrinologiya (Rus.), 2006, vol. 14, no. 26, pp. 1905–1911.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © Ya.N. Kotova, E.A. Kostanova, M.A. Rozenfel’d, E.I. Sinauridze, M.A. Panteleev, F.I. Ataullakhanov, 2009, published in Biologicheskie Membrany, 2009, Vol. 26, No. 6, pp. 514–520.
The article was translated by the authors.
Rights and permissions
About this article
Cite this article
Kotova, Y.N., Kostanova, E.A., Rozenfel’d, M.A. et al. Influence of cysteine proteinase inhibitors on platelet and plasma components of blood coagulation system. Biochem. Moscow Suppl. Ser. A 3, 447–452 (2009). https://doi.org/10.1134/S1990747809040126
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990747809040126